Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04481945Phase 4Completed
Phase 4, randomised trial (3 arms), sponsored by Misr International University. Primary endpoint: Antibacterial efficacy at 24 hours. Started Jun 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04481945.